Page 18 - Genmark Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roche to buy Covid test maker GenMark Diagnostics for $1.8 bn

Under the terms of the merger agreement, Roche will promptly commence a tender offer to acquire all outstanding shares of GenMark’s common stock, and GenMark will file a recommendation statement containing the unanimous recommendation of the GenMark board that GenMark stockholders tender their shares to Roche

/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GenMark Diagnostics,...

- Molecular Partners [MOLN.CH] +5% (trial), AstraZeneca [AZN.UK] -1% (Ireland suspends use of vaccine) - Speakers - BOE Gov Bailey0reiterated stance that current lockdown was having less effect on economy compared to a year ago. Had a more balanced picture on risks and could see a spending of savings and viewed as an upside risk. Very helpful that furlough scheme to extend beyond end of covid restrictions. Would expect a pickup in inflation towards 2% in the coming months; but question was whether such gains are sustainable; not expecting inflation to rise to 4.0-5.0% area. BOE is not out...

Roche has inked a $1.8 billion, all-cash deal for GenMark Diagnostics, to acquire its molecular tests designed to screen patient samples for multiple infections simultaneously.